Bioelectronics Corp (BIEL)

[Simpsonly]

Can you imagine, for just one minute of silence and contemplation, the impact on BIEL when the dysmenorrhea trial data in England on menstrual pain and cramping, due April 1, leads the NHS, the British National Health Service, adds BIEL’s Allay to its coverage Tariff, knowing the April 1 (next Sunday!!!!) addition of ActiPatch for chronic pain is estimated (by NHS) to save the service hundreds of millions of pounds annually over the current cost of drugs? Women deserve a break today! About time....

Tsunami baby, you know when.....next week and imminent....